ROTARY APPARATUS FOR PRE-STRETCHING AND DEEP-DRAWING,申请号EP19890112450-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	ROTARY APPARATUS FOR PRE-STRETCHING AND DEEP-DRAWING
摘要
申请公布号	EP0353490(A3)	申请公布日期	1991.03.27
申请号	EP19890112450	申请日期	1989.07.07
申请人	GRAMMER SITZSYSTEME GMBH	发明人	UBELACKER, HORST;STORCH, HELMUT;BUCHWALD, PETER
分类号	B29C44/14;B29C51/04;B29C51/22;(IPC1-7):B29C51/22	主分类号	B29C44/14
代理机构		代理人
主权项
地址

您可能感兴趣的专利

DISPLACEMENT TRANSDUCER

METHOD FOR DIAGNOSING INCREASED RIGIDITY OF VASCULAR WALL IN CHILDREN AT INCREASED RISK OF EARLY ATHEROSCLEROSIS

INSTALLATION FOR ELECTRIC HEATING OF PREMISES

METHOD FOR DRYING MATERIALS

METHOD FOR REMOVAL OF OIL AND OIL PRODUCTS FROM SOILS

Method for surgical treatment of Dupuytren's disease

METHOD FOR ADAPTIVE CHANGE OF OFDM-SYMBOL CYCLIC PREFIX LENGTH WHILE FORMING OFDM-SYGNALS

diagnostic line of microprism strabismus compensators

Anticuerpo humano aislado o un fragmento de union al antigeno del mismo porque se une o bloquea la actividad biológica de gdf-8 humano maduro de tipo natural; composicion farmacéutica que comprende dicho anticuerpo o el fragmento de unión al antígeno; uso del anticuerpo para tratar una enfermedad o trastorno tratable mediante la inhibición de la actividad de gdf-8.

IMPROVED AMINO ACID SEQUENCES DIRECTED AGAINST IL-6R AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF IL-6R RELATED DISEASES AND DISORDERS

MOUNTING MEANS FOR MOUNTING NATURAL STONE COMPRISING A SPRING AS A SECURING ELEMENT

CHEMICAL COMPOUNDS for treating Hepatitis C virus

THERAPEUTIC APPLICATIONS OF ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH DECTIN-1

Composicion que comprende el peptido amiloide beta 1-6 acoplado a una particula similar a virus y un auxiliar; vacuna que comprende la composicion; uso de la composicion para tratar o prevenir demencia y enfermedad de alzheimer.

PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK

FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES

ANTI-MST1R ANTIBODIES AND USES THEREOF

MULTILAYER, TUBE-SHAPED FOOD FILM

DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF

Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros.